MYD88 and COVID-19: In the current study, we report that the levels of TLR1/2-MyD88 signaling components, the NF-κB complex, and IRF1 were significantly increased as a function of the severity of COVID-19, and the results were consistent with expression levels of IL27 subunits in COVID-19 patients.